Powered by FinancialMarketMovers.com
We just ran our screens and wanted to point out 6 'Strong Buy' Stocks that you might want to keep an eye on....Keep in mind, these are very volatile stocks so please do your own research before you make any investments. We are not recommending these stocks.
If you have other stocks that you are researching, then you need to Join TipRanks.com Now to get insights on every stock being traded!Alphabet Class C, GOOG
Summary: Alphabet Inc. is engaged in technology business. The Company provides web-based search, advertisements, maps, software applications, mobile operating systems, consumer content, enterprise solutions, commerce and hardware products through its subsidiaries. Alphabet Inc., formerly known as Google Inc., is headquartered in Mountain View, California.
- Last Price: $126.72
- Price Change: $3.47, 2.82%
- Yearly Gain: 10.37%
- Market Cap: $1.56T
- P/E Ratio: 27.824
Here are 3rd party ratings for GOOG:
- TipRanks.com: Strong Buy
- TradingView.com: n/a (possibly response change)
- Yahoo! Finance: Bullish Short-Term Outlook
- Barchart.com: Strong buy
- Zacks.com: ,
What is the sentiment on the street regarding Alphabet Class C ? (Current ratings compiled by TipRanks.com)
- News Sentiment: Very Bullish
- Blogger Consensus: Bullish
- Media Buzz: Medium
- Insider Signal: Very Negative
- Investor Sentiment: Very Positive
- Hedge Fund signal: Very Negative
If you are interested in GOOG or any stocks within the Technology sector, you might want to click here and check out this report. The stock market is extremely volatile, and you need to do your own research on GOOG before you decide to make any investment.
Click here for chart >>
Nvidia, NVDA
Summary: NVIDIA Corporation is the worldwide leader in visual computing technologies and the inventor of the graphic processing unit, or GPU. Over the years, the company's focus has evolved from PC graphics to artificial intelligence (AI) based solutions that now support high performance computing (HPC), gaming and virtual reality (VR) platforms.NVIDIA's GPU success can be attributed to its parallel processing capabilities supported by thousands of computing cores, which are necessary to run deep learning algorithms. The company's GPU platforms are playing a major role in developing multi-billion-dollar end-markets like robotics and self-driving vehicles.NVIDIA is a dominant name in the Data Center, professional visualization and gaming markets where Intel and Advanced Micro Devices are playing a catch-up role. The company's partnership with almost all major cloud service providers (CSPs) and server vendors is a key catalyst.
- Last Price: $310.82
- Price Change: -$1.82, -0.58%
- Yearly Gain: 85.19%
- Market Cap: $772.22B
- P/E Ratio: 179.441
Here are 3rd party ratings for NVDA:
- TipRanks.com: Strong Buy
- TradingView.com: n/a (possibly response change)
- Yahoo! Finance: Bearish Short-Term Outlook
- Barchart.com: Strong buy
- Zacks.com: ,
What is the sentiment on the street regarding Nvidia ? (Current ratings compiled by TipRanks.com)
- News Sentiment: Very Bullish
- Blogger Consensus: Bullish
- Media Buzz: High
- Insider Signal: Negative
- Investor Sentiment: Very Positive
- Hedge Fund signal: Very Positive
If you are interested in NVDA or any stocks within the Technology sector, you might want to click here and check out this report. The stock market is extremely volatile, and you need to do your own research on NVDA before you decide to make any investment.
Click here for chart >>
Vertex Pharmaceuticals, VRTX
Summary: Vertex Pharmaceuticals Incorporated is focused on the discovery, development, and commercialization of small molecule drugs targeting serious diseases. The company's main area of focus is cystic fibrosis. The company's lead marketed products are Trikafta, Symdeko/Symkevi, Orkambi and Kalydeco, which are collectively approved to treat the people with CF in North America, Europe and Australia. Trikafta, Vertex's triple combination regimen, was approved by the FDA for the treatment of CF in people aged 12 years and older who have at least one F508del mutation. While CF remains the main area of focus, Vertex is also developing treatments for sickle cell disease, beta thalassemia, APOL1-mediated kidney disease, type 1 diabetes, pain, alpha-1 antitrypsin deficiency and muscular dystrophies. Pimodivir/VX-787, for the treatment of influenza, was out-licensed to Janssen while oncology candidates VX-970, VX-984 and VX-803 were divested to Merck KGaA.
- Last Price: $343.5
- Price Change: $1.8, 0.53%
- Yearly Gain: 32.14%
- Market Cap: $88.01B
- P/E Ratio: 27.22
Here are 3rd party ratings for VRTX:
- TipRanks.com: Strong Buy
- TradingView.com: n/a (possibly response change)
- Yahoo! Finance: Bearish Short-Term Outlook
- Barchart.com: Strong buy
- Zacks.com: ,
What is the sentiment on the street regarding Vertex Pharmaceuticals ? (Current ratings compiled by TipRanks.com)
- News Sentiment: Very Bullish
- Blogger Consensus: Bullish
- Media Buzz: Very Low
- Insider Signal: ―
- Investor Sentiment: Very Positive
- Hedge Fund signal: Very Positive
If you are interested in VRTX or any stocks within the Healthcare sector, you might want to click here and check out this report. The stock market is extremely volatile, and you need to do your own research on VRTX before you decide to make any investment.
Click here for chart >>
Uber Technologies, UBER
Summary: Uber Technologies Inc. provides a platform which allows users to access transportation and food ordering services. The Company's operating segments consist of Core Platform and Other Bets. The Core Platform segment consists of Ridesharing and Uber Eats. The Other Bets segment consists of Uber Freight and New Mobility platforms. Uber Technologies Inc. is based in San Francisco, CA.
- Last Price: $39.6
- Price Change: $0.42, 1.07%
- Yearly Gain: 67.79%
- Market Cap: $79.29B
- P/E Ratio: -22.793
Here are 3rd party ratings for UBER:
- TipRanks.com: Strong Buy
- TradingView.com: n/a (possibly response change)
- Yahoo! Finance: Bearish Short-Term Outlook
- Barchart.com: Strong buy
- Zacks.com: ,
What is the sentiment on the street regarding Uber Technologies ? (Current ratings compiled by TipRanks.com)
- News Sentiment: Very Bullish
- Blogger Consensus: Bullish
- Media Buzz: Low
- Insider Signal: ―
- Investor Sentiment: Positive
- Hedge Fund signal: Very Negative
If you are interested in UBER or any stocks within the Industrial Goods sector, you might want to click here and check out this report. The stock market is extremely volatile, and you need to do your own research on UBER before you decide to make any investment.
Click here for chart >>
Alphabet Class A, GOOGL
Summary: Alphabet has evolved from primarily being a search-engine provider to cloud computing, ad-based video and music streaming, autonomous vehicles, healthcare providers and others. In the online search arena, Google is a monopoly with more than 94% of the online search volume and market. Over the years, the company has witnessed increase in search queries, resulting from ongoing growth in user adoption and usage, primarily on mobile devices, continued growth in advertiser activity, and improvements in ad formats. The company is gaining market share in the cloud-computing, driven by continued strength in Google Cloud Platform and Google Workspace. Alphabet also enjoys a dominant position in the autonomous vehicles market, thanks to Waymo's relentless efforts. Also, it has bolstered its footprint in the healthcare industry with its life science division, Verily.
- Last Price: $126.1
- Price Change: $3.34, 2.72%
- Yearly Gain: 10.11%
- Market Cap: $1.56T
- P/E Ratio: 27.713
Here are 3rd party ratings for GOOGL:
- TipRanks.com: Strong Buy
- TradingView.com: n/a (possibly response change)
- Yahoo! Finance: Bullish Short-Term Outlook
- Barchart.com: Strong buy
- Zacks.com: ,
What is the sentiment on the street regarding Alphabet Class A ? (Current ratings compiled by TipRanks.com)
- News Sentiment: Very Bullish
- Blogger Consensus: Bullish
- Media Buzz: Medium
- Insider Signal: ―
- Investor Sentiment: Neutral
- Hedge Fund signal: Negative
If you are interested in GOOGL or any stocks within the Technology sector, you might want to click here and check out this report. The stock market is extremely volatile, and you need to do your own research on GOOGL before you decide to make any investment.
Click here for chart >>
AmerisourceBergen, ABC
Summary: AmerisourceBergen is one of the world's largest pharmaceutical services companies, which focuses on providing drug distribution and related services to reduce health care costs and improve patient outcomes. The company reports through two segments: Pharmaceutical Distribution and Other. The Pharmaceutical Distribution business includes the operations of AmerisourceBergen Drug Corporation and AmerisourceBergen Specialty Group. The segment services healthcare providers in the pharmaceutical supply channel. The ABSG division provides pharmaceutical distribution and other servicesto physicians, who specialize in a variety of diseases, especially oncology, and to other health care providers. The ABDC division is involved in the distribution of branded pharma drugs and generic drugs, over-the-counter healthcare products, home healthcare supplies and equipment to healthcare providers. The 'Other' segment consists of AmerisourceBergen Consulting Services, World Courier and MWI Veterinary Supply.
- Last Price: $173.14
- Price Change: -$0.25, -0.14%
- Yearly Gain: 16.86%
- Market Cap: $35.11B
- P/E Ratio: 22.473
Here are 3rd party ratings for ABC:
- TipRanks.com: Strong Buy
- TradingView.com: n/a (possibly response change)
- Yahoo! Finance: Bearish Short-Term Outlook
- Barchart.com: Strong buy
- Zacks.com: ,
What is the sentiment on the street regarding AmerisourceBergen ? (Current ratings compiled by TipRanks.com)
- News Sentiment: Very Bullish
- Blogger Consensus: Bullish
- Media Buzz: Medium
- Insider Signal: Negative
- Investor Sentiment: Very Positive
- Hedge Fund signal: Very Positive
If you are interested in ABC or any stocks within the Healthcare sector, you might want to click here and check out this report. The stock market is extremely volatile, and you need to do your own research on ABC before you decide to make any investment.
Click here for chart >>
Thanks for reading!